Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2

Sponsor Class

NETWORK 8OTHER 3NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gynecologic 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 7Melanoma 5Leukemia 5Colonic Neoplasms 5Rectal Neoplasms 4Leukemia, Myeloid, Acute 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Lymphoma, Follicular 3Fallopian Tube Neoplasms 3Congenital Abnormalities 3Colorectal Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Mesothelioma, Malignant 2Lymphoma 2Lung Neoplasms 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Head and Neck Neoplasms 2Waldenstrom Macroglobulinemia 1

Interventions

Doxorubicin 20Cyclophosphamide 18Radiotherapy 17Ifosfamide 13Vincristine 12Magnetic Resonance Spectroscopy 12Specimen Handling 11Biopsy 10Etoposide 9Filgrastim 8Dactinomycin 8X-Rays 6Temozolomide 6Sirolimus 6Phantoms, Imaging 6Melphalan 6temsirolimus 5cixutumumab 5Thalidomide 5Celecoxib 5Sorafenib 4Radiation 4Nuclear Medicine Department, Hospital 4Ipilimumab 4Fluorodeoxyglucose F18 4Chemotherapy, Adjuvant 4Carboplatin 4pazopanib 3ixabepilone 3cabozantinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Sarcoma × Gene Expression Profiling × Clear all
NCT00601406 2013-08-26

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

National Cancer Institute (NCI)

Phase NA Unknown
2,200 enrolled
BreastGenitourinaryGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Male

NCT00514345 2013-08-12

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

National Cancer Institute (NCI)

Unknown
300 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡